These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 34492555)
1. Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups - United States, 2004-2019. Kariisa M; Seth P; Scholl L; Wilson N; Davis NL Drug Alcohol Depend; 2021 Oct; 227():109001. PubMed ID: 34492555 [TBL] [Abstract][Full Text] [Related]
2. Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017. Kariisa M; Scholl L; Wilson N; Seth P; Hoots B MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):388-395. PubMed ID: 31048676 [TBL] [Abstract][Full Text] [Related]
3. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States. Hoots B; Vivolo-Kantor A; Seth P Addiction; 2020 May; 115(5):946-958. PubMed ID: 31912625 [TBL] [Abstract][Full Text] [Related]
4. Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999-2018. Rawy M; Abdalla G; Look K BMC Public Health; 2024 Jan; 24(1):112. PubMed ID: 38184563 [TBL] [Abstract][Full Text] [Related]
5. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021. Friedman J; Shover CL Addiction; 2023 Dec; 118(12):2477-2485. PubMed ID: 37705148 [TBL] [Abstract][Full Text] [Related]
6. Opioid and stimulant attributed treatment admissions and fatal overdoses: Using national surveillance data to examine the intersection of race, sex, and polysubstance use, 1992-2020. Jones AA; Shearer RD; Segel JE; Santos-Lozada A; Strong-Jones S; Vest N; Teixeira da Silva D; Khatri UG; Winkelman TNA Drug Alcohol Depend; 2023 Aug; 249():109946. PubMed ID: 37354584 [TBL] [Abstract][Full Text] [Related]
7. Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids. Cano M; Huang Y Drug Alcohol Depend; 2021 Jan; 218():108384. PubMed ID: 33158665 [TBL] [Abstract][Full Text] [Related]
8. Changing Trends in Drug Overdose Mortality in Kentucky: An Examination of Race and Ethnicity, Age, and Contributing Drugs, 2016-2020. Slavova S; Freeman PR; Rock P; Brancato C; Hargrove S; Liford M; Quesinberry D; Walsh SL Public Health Rep; 2023; 138(1):131-139. PubMed ID: 35184586 [TBL] [Abstract][Full Text] [Related]
9. The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis. Estadt AT; White BN; Ricks JM; Lancaster KE; Hepler S; Miller WC; Kline D Harm Reduct J; 2024 Jan; 21(1):13. PubMed ID: 38233924 [TBL] [Abstract][Full Text] [Related]
10. Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011-2021. Spencer MR; Miniño AM; Garnett MF NCHS Data Brief; 2023 Jul; (474):1-8. PubMed ID: 37486676 [TBL] [Abstract][Full Text] [Related]
11. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019. Mattson CL; Tanz LJ; Quinn K; Kariisa M; Patel P; Davis NL MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(6):202-207. PubMed ID: 33571180 [TBL] [Abstract][Full Text] [Related]
12. Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid-Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas - United States, 2015-2017. Lippold KM; Jones CM; Olsen EO; Giroir BP MMWR Morb Mortal Wkly Rep; 2019 Nov; 68(43):967-973. PubMed ID: 31671083 [TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic differences in US drug overdose mortality, 2017-2018. Cano M Addict Behav; 2021 Jan; 112():106625. PubMed ID: 32916612 [TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic trends in opioid and polysubstance opioid overdose mortality in adolescents and young adults, 1999-2020. Brinzo PN; Martins SS Addict Behav; 2024 Sep; 156():108065. PubMed ID: 38772226 [TBL] [Abstract][Full Text] [Related]
16. Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007-2019. Townsend T; Kline D; Rivera-Aguirre A; Bunting AM; Mauro PM; Marshall BDL; Martins SS; Cerdá M Am J Epidemiol; 2022 Mar; 191(4):599-612. PubMed ID: 35142341 [TBL] [Abstract][Full Text] [Related]
17. Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration. Coughlin LN; Zhang L; Bohnert ASB; Maust DT; Goldstick J; Lin LA Addiction; 2022 Apr; 117(4):998-1008. PubMed ID: 34648209 [TBL] [Abstract][Full Text] [Related]
18. Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019. O'Donnell J; Gladden RM; Mattson CL; Hunter CT; Davis NL MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1189-1197. PubMed ID: 32881854 [TBL] [Abstract][Full Text] [Related]
19. State-Level History of Overdose Deaths Involving Stimulants in the United States, 1999‒2020. Kline D; Bunting AM; Hepler SA; Rivera-Aguirre A; Krawczyk N; Cerda M Am J Public Health; 2023 Sep; 113(9):991-999. PubMed ID: 37556789 [No Abstract] [Full Text] [Related]
20. Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019 to 2022. Hébert AH; Hill AL Lancet Reg Health Am; 2024 Aug; 36():100813. PubMed ID: 38978785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]